New gene discovery can help repair heart damage from heart attack or heart failure

Your heart will not just give you fear and uncertainty after a heart attack; it can leave scar tissue that stiffens your ...
TipRanks on MSN

Precision Biotech Wave Builds As FDA Expedites Breakthrough Cell And Gene Therapies

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

Sangamo targets Q1 2026 BLA submission for Fabry gene therapy as FDA affirms accelerated pathway

Q3 2025 Management View CEO Alexander Macrae highlighted continued advancement of the clinical and preclinical pipeline, with a focus on managing cash resources. Macrae stated, "In September, we ...

Pluristyx Executes Key Commercial Clinical Use Licenses for iPSC Portfolio, Enabling Novel Therapies for Regenerative Medicine and Neurological Disease Therapeutics

Pluristyx's iPSC platform provides therapeutic developers with a streamlined path from research to clinical application, offering high-quality, regulatory-compliant starting materials and advanced ...

Biotechnology: Pioneering The Future Of Medicine

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

Gene Therapy Platform Market Projected to Surpass USD 7.50 Billion by 2032, Driven by Rapid Advances in CRISPR and Viral Vector Technologies – SNS Insider

Emerging biotechnologies, strategic collaborations, and growing focus on personalized and regenerative medicine are accelerating the next wave of gene therapy innovation.Austin, Nov. 05, 2025 (GLOBE ...
Scientific American

Gene Editing Helped One Baby—Could It Help Thousands?

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the ...

PPMD Provides $400,000 in Funding to MyoGene Bio Through PPMD Venture Pathways Program to Support Development of Gene Editing Platform

Parent Project Muscular Dystrophy (PPMD), the largest U.S. non-profit leading Duchenne and Becker muscular dystrophy care, research, and advocacy efforts, and MyoGene Bio (MyoGene) are excited to ...
TechCentral.ie

Gene therapy project sees viruses as the way forward in developing affordable and effective treatments

As a new €2 million gene therapy research project funded by APC Microbiome Ireland and Research Ireland is announced, we speak with the project lead Prof Niall Barron about its potential and how ...

AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced the publication in peer-reviewed journal Nature Medicine of 12-month ...
Healio

FDA grants regenerative medicine advanced therapy designation to XLRS gene therapy

Please provide your email address to receive an email when new articles are posted on . The designation is intended to expedite the drug development and review process. This is the fourth designation ...
FierceBiotech

Prime Medicine CEO exits as biotech shelves sole clinical gene therapy, lays off 25% of staff

Despite hitting a clinical “milestone,” Prime Medicine is shelving its sole clinical-stage genetic medicine. The Cambridge, Massachusetts-based biotech is also laying off staffers and CEO Keith ...